\BOOKMARK [0][-]{Doc-Start}{DEDICATION}{}% 1
\BOOKMARK [0][-]{Doc-Start}{ACKNOWLEDGEMENTS}{}% 2
\BOOKMARK [0][-]{Doc-Start}{LIST OF FIGURES}{}% 3
\BOOKMARK [0][-]{Doc-Start}{LIST OF TABLES}{}% 4
\BOOKMARK [0][-]{Doc-Start}{ABSTRACT}{}% 5
\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 6
\BOOKMARK [1][-]{section.1.1}{Introduction}{chapter.1}% 7
\BOOKMARK [1][-]{section.1.2}{Background}{chapter.1}% 8
\BOOKMARK [2][-]{subsection.1.2.1}{Histone modifications}{section.1.2}% 9
\BOOKMARK [2][-]{subsection.1.2.2}{DNA methylation}{section.1.2}% 10
\BOOKMARK [2][-]{subsection.1.2.3}{Gene set enrichment}{section.1.2}% 11
\BOOKMARK [2][-]{subsection.1.2.4}{Metabolomics}{section.1.2}% 12
\BOOKMARK [1][-]{section.1.3}{Dissertation overview}{chapter.1}% 13
\BOOKMARK [2][-]{subsection.1.3.1}{Chapter II: Broad-Enrich}{section.1.3}% 14
\BOOKMARK [2][-]{subsection.1.3.2}{Chapter III: ConceptMetab}{section.1.3}% 15
\BOOKMARK [2][-]{subsection.1.3.3}{Chapter IV: annotatr}{section.1.3}% 16
\BOOKMARK [2][-]{subsection.1.3.4}{Chapter V: mint}{section.1.3}% 17
\BOOKMARK [0][-]{chapter.2}{Broad-Enrich: Functional interpretation of large sets of broad genomic regions}{}% 18
\BOOKMARK [1][-]{section.2.1}{Introduction}{chapter.2}% 19
\BOOKMARK [1][-]{section.2.2}{Methods}{chapter.2}% 20
\BOOKMARK [2][-]{subsection.2.2.1}{Gene locus definitions}{section.2.2}% 21
\BOOKMARK [2][-]{subsection.2.2.2}{Proportional assignment of peaks to genes}{section.2.2}% 22
\BOOKMARK [2][-]{subsection.2.2.3}{Annotation databases}{section.2.2}% 23
\BOOKMARK [2][-]{subsection.2.2.4}{Broad-Enrich method for functional enrichment testing}{section.2.2}% 24
\BOOKMARK [2][-]{subsection.2.2.5}{Experimental ChIP-seq peak datasets}{section.2.2}% 25
\BOOKMARK [2][-]{subsection.2.2.6}{Standard peak calling pipeline}{section.2.2}% 26
\BOOKMARK [2][-]{subsection.2.2.7}{Power study comparing Broad-Enrich to Fisher's exact test}{section.2.2}% 27
\BOOKMARK [2][-]{subsection.2.2.8}{Permutations to test type I error rate}{section.2.2}% 28
\BOOKMARK [2][-]{subsection.2.2.9}{Alternative functional enrichment testing methods}{section.2.2}% 29
\BOOKMARK [1][-]{section.2.3}{Results}{chapter.2}% 30
\BOOKMARK [2][-]{subsection.2.3.1}{Differences between histone and transcription-factor based ChIP-seq data}{section.2.3}% 31
\BOOKMARK [2][-]{subsection.2.3.2}{Broad-Enrich method}{section.2.3}% 32
\BOOKMARK [2][-]{subsection.2.3.3}{Investigation of type I error}{section.2.3}% 33
\BOOKMARK [2][-]{subsection.2.3.4}{Summary of ENCODE histone modification enrichment results}{section.2.3}% 34
\BOOKMARK [2][-]{subsection.2.3.5}{Comparison of Broad-Enrich to Fisherâ€™s exact test and GREAT}{section.2.3}% 35
\BOOKMARK [2][-]{subsection.2.3.6}{Effect of locus definition on enrichment}{section.2.3}% 36
\BOOKMARK [1][-]{section.2.4}{Discussion}{chapter.2}% 37
\BOOKMARK [0][-]{chapter.3}{ConceptMetab: Exploring relationships among metabolite sets to identify links among biomedical concepts}{}% 38
\BOOKMARK [1][-]{section.3.1}{Introduction}{chapter.3}% 39
\BOOKMARK [1][-]{section.3.2}{Methods}{chapter.3}% 40
\BOOKMARK [2][-]{subsection.3.2.1}{Mapping small molecules to annotations}{section.3.2}% 41
\BOOKMARK [2][-]{subsection.3.2.2}{Compound dictionary}{section.3.2}% 42
\BOOKMARK [2][-]{subsection.3.2.3}{Metabolite set enrichment testing}{section.3.2}% 43
\BOOKMARK [2][-]{subsection.3.2.4}{Visualizing relationships among concepts}{section.3.2}% 44
\BOOKMARK [2][-]{subsection.3.2.5}{Visualizing metabolite sets as networks in MetScape}{section.3.2}% 45
\BOOKMARK [1][-]{section.3.3}{Results}{chapter.3}% 46
\BOOKMARK [2][-]{subsection.3.3.1}{Overview of ConceptMetab database}{section.3.3}% 47
\BOOKMARK [2][-]{subsection.3.3.2}{ConceptMetab workflow}{section.3.3}% 48
\BOOKMARK [2][-]{subsection.3.3.3}{Significant relationships among metabolite annotation sources}{section.3.3}% 49
\BOOKMARK [2][-]{subsection.3.3.4}{Comparing biological associations based on metabolites to those based on genes}{section.3.3}% 50
\BOOKMARK [2][-]{subsection.3.3.5}{Using ConceptMetab to understand the molecular/anatomical risks and effects of a disease}{section.3.3}% 51
\BOOKMARK [2][-]{subsection.3.3.6}{Using ConceptMetab to investigate the diseases associated with an aberrant biological process}{section.3.3}% 52
\BOOKMARK [2][-]{subsection.3.3.7}{Exploring relationships between metabolic pathways and diseases}{section.3.3}% 53
\BOOKMARK [2][-]{subsection.3.3.8}{Using ConceptMetab to explore the biological roles of a metabolite}{section.3.3}% 54
\BOOKMARK [1][-]{section.3.4}{Discussion}{chapter.3}% 55
\BOOKMARK [0][-]{chapter.4}{annotatr: Genomic regions in context}{}% 56
\BOOKMARK [1][-]{section.4.1}{Introduction}{chapter.4}% 57
\BOOKMARK [1][-]{section.4.2}{Methods}{chapter.4}% 58
\BOOKMARK [2][-]{subsection.4.2.1}{Construction of genomic annotations}{section.4.2}% 59
\BOOKMARK [3][-]{section*.5}{CpG features}{subsection.4.2.1}% 60
\BOOKMARK [3][-]{section*.6}{Genic features}{subsection.4.2.1}% 61
\BOOKMARK [3][-]{section*.7}{lncRNA features}{subsection.4.2.1}% 62
\BOOKMARK [3][-]{section*.8}{Enhancer features}{subsection.4.2.1}% 63
\BOOKMARK [3][-]{section*.9}{Chromatin state features}{subsection.4.2.1}% 64
\BOOKMARK [3][-]{section*.10}{AnnotationHub resources}{subsection.4.2.1}% 65
\BOOKMARK [2][-]{subsection.4.2.2}{Benchmarking with microbenchmark and lineprof}{section.4.2}% 66
\BOOKMARK [1][-]{section.4.3}{Results}{chapter.4}% 67
\BOOKMARK [2][-]{subsection.4.3.1}{Implementation and features}{section.4.3}% 68
\BOOKMARK [2][-]{subsection.4.3.2}{Benchmarking}{section.4.3}% 69
\BOOKMARK [1][-]{section.4.4}{Discussion}{chapter.4}% 70
\BOOKMARK [0][-]{chapter.5}{Integrating DNA methylation and hydroxymethylation data with the mint pipeline}{}% 71
\BOOKMARK [1][-]{section.5.1}{Introduction}{chapter.5}% 72
\BOOKMARK [1][-]{section.5.2}{Methods}{chapter.5}% 73
\BOOKMARK [2][-]{subsection.5.2.1}{Overview of the mint pipeline}{section.5.2}% 74
\BOOKMARK [2][-]{subsection.5.2.2}{Demonstration data}{section.5.2}% 75
\BOOKMARK [1][-]{section.5.3}{Results}{chapter.5}% 76
\BOOKMARK [2][-]{subsection.5.3.1}{Alignment modules}{section.5.3}% 77
\BOOKMARK [2][-]{subsection.5.3.2}{Sample modules}{section.5.3}% 78
\BOOKMARK [2][-]{subsection.5.3.3}{Comparison modules}{section.5.3}% 79
\BOOKMARK [2][-]{subsection.5.3.4}{Integration modules}{section.5.3}% 80
\BOOKMARK [2][-]{subsection.5.3.5}{Annotation and Genome Browser Tracks}{section.5.3}% 81
\BOOKMARK [1][-]{section.5.4}{Discussion}{chapter.5}% 82
\BOOKMARK [0][-]{chapter.6}{Conclusion}{}% 83
\BOOKMARK [1][-]{section.6.1}{Conclusions}{chapter.6}% 84
\BOOKMARK [1][-]{section.6.2}{Future Directions}{chapter.6}% 85
\BOOKMARK [2][-]{subsection.6.2.1}{Chapter II: Broad-Enrich}{section.6.2}% 86
\BOOKMARK [2][-]{subsection.6.2.2}{Chapter III: ConceptMetab}{section.6.2}% 87
\BOOKMARK [2][-]{subsection.6.2.3}{Chapter IV: annotatr}{section.6.2}% 88
\BOOKMARK [2][-]{subsection.6.2.4}{Chapter V: mint}{section.6.2}% 89
\BOOKMARK [1][-]{section.6.3}{Epilogue}{chapter.6}% 90
\BOOKMARK [0][-]{section.6.3}{BIBLIOGRAPHY}{}% 91
